Once among the hottest stocks in town, ASX-listed cannabis firms have fallen out of favour with investors and seen millions wiped off their valuations. Steve Jones speaks to industry experts to assess the damage and explore the reasons behind the decline.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Figuring out the vagaries of the stock market has never been straightforward.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...